Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 5 Oct 20 EFFECT Notice of effectiveness
- 2 Oct 20 424B3 Prospectus supplement
-
30 Sep 20 S-4/A Registration of securities issued in business combination transactions (amended)
- 15 Sep 20 S-4/A Registration of securities issued in business combination transactions (amended)
- 27 Aug 20 S-4/A Registration of securities issued in business combination transactions (amended)
- 6 Jul 20 S-4 Registration of securities issued in business combination transactions
OCUP similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We hereby consent to the incorporation by reference and use in the Prospectus constituting a part of this Registration Statement of our report dated February 21, 2020, relating to the financial statements of Rexahn Pharmaceuticals, Inc. appearing in the entity’s Annual Report on Form 10-K for the year ended December 31, 2019.
We also consent to the references to us under the caption “Experts” in the Prospectus.
/s/ Baker Tilly US, LLP (formerly known as Baker Tilly Virchow Krause, LLP)
Philadelphia, Pennsylvania
September 29, 2020